Table 4 Characteristics of the male sub-sample with gene expression profiling and cholesterol efflux measurements compared with male control subjects
From: Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
Hypertriglyceridemia | Controls | p-values | |
|---|---|---|---|
n = 6 | n = 9 | ||
Age (years) | 44 (32-50) | 52 (25-60) | 0.41 |
Total cholesterol (mmol/L) | 8.9 (5.2-14.6) | 4.5 (3.7-5.6) | 0.004 |
LDL cholesterol (mmol/L) | 2.3 (1.9-3.8) | 2.9 (2.0-4.1) | 0.41 |
HDL cholesterol (mmol/L) | 1.4 (0.8-2.4) | 1.5 (1.1-2.0) | 0.63 |
Triglycerides (mmol/L) | 17.3 (5.1-58) | 0.7 (0.4-1.5) | 0.001 |
Apolipoprotein A1 (mg/L) | 1.1 (1.1-1.4) | 1.5 (1.1-1.7) | 0.019 |
Apolipoprotein B (mg/L) | 0.8 (0.7-1.1) | 0.8 (0.6-1.1) | 0.58 |
Free fatty acids (nmol/L) | 593 (372-798) | 387 (172-681) | 0.090 |
Hs-CRP (mg/L) | 2.4 (0.7-20) | 1.1 (0.7-2.8) | 0.20 |
Glucose (mmol/L) | 10.1 (5.5-14.7) | 5.0 (4.4-5.4) | 0.001 |